COVID-19 Impact on Global Cancer Hormone Therapy Drugs Market Size, Status and Forecast 2020-2026

August 2020 | 93 pages | ID: CA2D7BB44645EN
QYResearch

Abstracts

This report focuses on the global Cancer Hormone Therapy Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Hormone Therapy Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Roche
• Amgen
• Pfizer
• Teva
• Takeda
• Samyang Biopharmaceuticals
• Tolmar
• AstraZeneca
• Novartis
• Aspen

Market segment by Type, the product can be split into

• Tamoxifen
• Aromatase Inhibitors
• Antiandrogens
• Androgen Synthesis Inhibitors
• Other

Market segment by Application, split into

• Breast Cancer
• Prostate Cancer

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Cancer Hormone Therapy Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Cancer Hormone Therapy Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Hormone Therapy Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Hormone Therapy Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Tamoxifen
  1.4.3 Aromatase Inhibitors
  1.4.4 Antiandrogens
  1.4.5 Androgen Synthesis Inhibitors
  1.4.6 Other
1.5 Market by Application
  1.5.1 Global Cancer Hormone Therapy Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Breast Cancer
  1.5.3 Prostate Cancer
1.6 Coronavirus Disease 2019 (Covid-19): Cancer Hormone Therapy Drugs Industry Impact
  1.6.1 How the Covid-19 is Affecting the Cancer Hormone Therapy Drugs Industry
    1.6.1.1 Cancer Hormone Therapy Drugs Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Cancer Hormone Therapy Drugs Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Cancer Hormone Therapy Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Cancer Hormone Therapy Drugs Market Perspective (2015-2026)
2.2 Cancer Hormone Therapy Drugs Growth Trends by Regions
  2.2.1 Cancer Hormone Therapy Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Cancer Hormone Therapy Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Cancer Hormone Therapy Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Cancer Hormone Therapy Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Cancer Hormone Therapy Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Cancer Hormone Therapy Drugs Players by Market Size
  3.1.1 Global Top Cancer Hormone Therapy Drugs Players by Revenue (2015-2020)
  3.1.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Cancer Hormone Therapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Hormone Therapy Drugs Market Concentration Ratio
  3.2.1 Global Cancer Hormone Therapy Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Cancer Hormone Therapy Drugs Revenue in 2019
3.3 Cancer Hormone Therapy Drugs Key Players Head office and Area Served
3.4 Key Players Cancer Hormone Therapy Drugs Product Solution and Service
3.5 Date of Enter into Cancer Hormone Therapy Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Type (2015-2020)
4.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2021-2026)

5 CANCER HORMONE THERAPY DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)
5.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Cancer Hormone Therapy Drugs Market Size (2015-2020)
6.2 Cancer Hormone Therapy Drugs Key Players in North America (2019-2020)
6.3 North America Cancer Hormone Therapy Drugs Market Size by Type (2015-2020)
6.4 North America Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Cancer Hormone Therapy Drugs Market Size (2015-2020)
7.2 Cancer Hormone Therapy Drugs Key Players in Europe (2019-2020)
7.3 Europe Cancer Hormone Therapy Drugs Market Size by Type (2015-2020)
7.4 Europe Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Cancer Hormone Therapy Drugs Market Size (2015-2020)
8.2 Cancer Hormone Therapy Drugs Key Players in China (2019-2020)
8.3 China Cancer Hormone Therapy Drugs Market Size by Type (2015-2020)
8.4 China Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Cancer Hormone Therapy Drugs Market Size (2015-2020)
9.2 Cancer Hormone Therapy Drugs Key Players in Japan (2019-2020)
9.3 Japan Cancer Hormone Therapy Drugs Market Size by Type (2015-2020)
9.4 Japan Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Cancer Hormone Therapy Drugs Market Size (2015-2020)
10.2 Cancer Hormone Therapy Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Hormone Therapy Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Cancer Hormone Therapy Drugs Market Size (2015-2020)
11.2 Cancer Hormone Therapy Drugs Key Players in India (2019-2020)
11.3 India Cancer Hormone Therapy Drugs Market Size by Type (2015-2020)
11.4 India Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Cancer Hormone Therapy Drugs Market Size (2015-2020)
12.2 Cancer Hormone Therapy Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Hormone Therapy Drugs Market Size by Type (2015-2020)
12.4 Central & South America Cancer Hormone Therapy Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Roche
  13.1.1 Roche Company Details
  13.1.2 Roche Business Overview and Its Total Revenue
  13.1.3 Roche Cancer Hormone Therapy Drugs Introduction
  13.1.4 Roche Revenue in Cancer Hormone Therapy Drugs Business (2015-2020))
  13.1.5 Roche Recent Development
13.2 Amgen
  13.2.1 Amgen Company Details
  13.2.2 Amgen Business Overview and Its Total Revenue
  13.2.3 Amgen Cancer Hormone Therapy Drugs Introduction
  13.2.4 Amgen Revenue in Cancer Hormone Therapy Drugs Business (2015-2020)
  13.2.5 Amgen Recent Development
13.3 Pfizer
  13.3.1 Pfizer Company Details
  13.3.2 Pfizer Business Overview and Its Total Revenue
  13.3.3 Pfizer Cancer Hormone Therapy Drugs Introduction
  13.3.4 Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2015-2020)
  13.3.5 Pfizer Recent Development
13.4 Teva
  13.4.1 Teva Company Details
  13.4.2 Teva Business Overview and Its Total Revenue
  13.4.3 Teva Cancer Hormone Therapy Drugs Introduction
  13.4.4 Teva Revenue in Cancer Hormone Therapy Drugs Business (2015-2020)
  13.4.5 Teva Recent Development
13.5 Takeda
  13.5.1 Takeda Company Details
  13.5.2 Takeda Business Overview and Its Total Revenue
  13.5.3 Takeda Cancer Hormone Therapy Drugs Introduction
  13.5.4 Takeda Revenue in Cancer Hormone Therapy Drugs Business (2015-2020)
  13.5.5 Takeda Recent Development
13.6 Samyang Biopharmaceuticals
  13.6.1 Samyang Biopharmaceuticals Company Details
  13.6.2 Samyang Biopharmaceuticals Business Overview and Its Total Revenue
  13.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Introduction
  13.6.4 Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2015-2020)
  13.6.5 Samyang Biopharmaceuticals Recent Development
13.7 Tolmar
  13.7.1 Tolmar Company Details
  13.7.2 Tolmar Business Overview and Its Total Revenue
  13.7.3 Tolmar Cancer Hormone Therapy Drugs Introduction
  13.7.4 Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2015-2020)
  13.7.5 Tolmar Recent Development
13.8 AstraZeneca
  13.8.1 AstraZeneca Company Details
  13.8.2 AstraZeneca Business Overview and Its Total Revenue
  13.8.3 AstraZeneca Cancer Hormone Therapy Drugs Introduction
  13.8.4 AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2015-2020)
  13.8.5 AstraZeneca Recent Development
13.9 Novartis
  13.9.1 Novartis Company Details
  13.9.2 Novartis Business Overview and Its Total Revenue
  13.9.3 Novartis Cancer Hormone Therapy Drugs Introduction
  13.9.4 Novartis Revenue in Cancer Hormone Therapy Drugs Business (2015-2020)
  13.9.5 Novartis Recent Development
13.10 Aspen
  13.10.1 Aspen Company Details
  13.10.2 Aspen Business Overview and Its Total Revenue
  13.10.3 Aspen Cancer Hormone Therapy Drugs Introduction
  13.10.4 Aspen Revenue in Cancer Hormone Therapy Drugs Business (2015-2020)
  13.10.5 Aspen Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Cancer Hormone Therapy Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Hormone Therapy Drugs Revenue
Table 3. Ranking of Global Top Cancer Hormone Therapy Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tamoxifen
Table 6. Key Players of Aromatase Inhibitors
Table 7. Key Players of Antiandrogens
Table 8. Key Players of Androgen Synthesis Inhibitors
Table 9. Key Players of Other
Table 10. COVID-19 Impact Global Market: (Four Cancer Hormone Therapy Drugs Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Cancer Hormone Therapy Drugs Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Cancer Hormone Therapy Drugs Players to Combat Covid-19 Impact
Table 15. Global Cancer Hormone Therapy Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Cancer Hormone Therapy Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Cancer Hormone Therapy Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Cancer Hormone Therapy Drugs Market Share by Regions (2015-2020)
Table 19. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Cancer Hormone Therapy Drugs Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Cancer Hormone Therapy Drugs Market Growth Strategy
Table 25. Main Points Interviewed from Key Cancer Hormone Therapy Drugs Players
Table 26. Global Cancer Hormone Therapy Drugs Revenue by Players (2015-2020) (Million US$)
Table 27. Global Cancer Hormone Therapy Drugs Market Share by Players (2015-2020)
Table 28. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Hormone Therapy Drugs as of 2019)
Table 29. Global Cancer Hormone Therapy Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Cancer Hormone Therapy Drugs Product Solution and Service
Table 32. Date of Enter into Cancer Hormone Therapy Drugs Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 35. Global Cancer Hormone Therapy Drugs Market Size Share by Type (2015-2020)
Table 36. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2021-2026)
Table 37. Global Cancer Hormone Therapy Drugs Market Size Share by Application (2015-2020)
Table 38. Global Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 39. Global Cancer Hormone Therapy Drugs Market Size Share by Application (2021-2026)
Table 40. North America Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020)
Table 42. North America Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 43. North America Cancer Hormone Therapy Drugs Market Share by Type (2015-2020)
Table 44. North America Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 45. North America Cancer Hormone Therapy Drugs Market Share by Application (2015-2020)
Table 46. Europe Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020)
Table 48. Europe Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Cancer Hormone Therapy Drugs Market Share by Type (2015-2020)
Table 50. Europe Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Cancer Hormone Therapy Drugs Market Share by Application (2015-2020)
Table 52. China Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$)
Table 53. China Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020)
Table 54. China Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 55. China Cancer Hormone Therapy Drugs Market Share by Type (2015-2020)
Table 56. China Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 57. China Cancer Hormone Therapy Drugs Market Share by Application (2015-2020)
Table 58. Japan Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020)
Table 60. Japan Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Cancer Hormone Therapy Drugs Market Share by Type (2015-2020)
Table 62. Japan Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Cancer Hormone Therapy Drugs Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020)
Table 66. Southeast Asia Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Cancer Hormone Therapy Drugs Market Share by Type (2015-2020)
Table 68. Southeast Asia Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Cancer Hormone Therapy Drugs Market Share by Application (2015-2020)
Table 70. India Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$)
Table 71. India Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020)
Table 72. India Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 73. India Cancer Hormone Therapy Drugs Market Share by Type (2015-2020)
Table 74. India Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 75. India Cancer Hormone Therapy Drugs Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Cancer Hormone Therapy Drugs Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Cancer Hormone Therapy Drugs Market Share (2019-2020)
Table 78. Central & South America Cancer Hormone Therapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Cancer Hormone Therapy Drugs Market Share by Type (2015-2020)
Table 80. Central & South America Cancer Hormone Therapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Cancer Hormone Therapy Drugs Market Share by Application (2015-2020)
Table 82. Roche Company Details
Table 83. Roche Business Overview
Table 84. Roche Product
Table 85. Roche Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$)
Table 86. Roche Recent Development
Table 87. Amgen Company Details
Table 88. Amgen Business Overview
Table 89. Amgen Product
Table 90. Amgen Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$)
Table 91. Amgen Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Product
Table 95. Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$)
Table 96. Pfizer Recent Development
Table 97. Teva Company Details
Table 98. Teva Business Overview
Table 99. Teva Product
Table 100. Teva Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$)
Table 101. Teva Recent Development
Table 102. Takeda Company Details
Table 103. Takeda Business Overview
Table 104. Takeda Product
Table 105. Takeda Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$)
Table 106. Takeda Recent Development
Table 107. Samyang Biopharmaceuticals Company Details
Table 108. Samyang Biopharmaceuticals Business Overview
Table 109. Samyang Biopharmaceuticals Product
Table 110. Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$)
Table 111. Samyang Biopharmaceuticals Recent Development
Table 112. Tolmar Company Details
Table 113. Tolmar Business Overview
Table 114. Tolmar Product
Table 115. Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$)
Table 116. Tolmar Recent Development
Table 117. AstraZeneca Business Overview
Table 118. AstraZeneca Product
Table 119. AstraZeneca Company Details
Table 120. AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$)
Table 121. AstraZeneca Recent Development
Table 122. Novartis Company Details
Table 123. Novartis Business Overview
Table 124. Novartis Product
Table 125. Novartis Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$)
Table 126. Novartis Recent Development
Table 127. Aspen Company Details
Table 128. Aspen Business Overview
Table 129. Aspen Product
Table 130. Aspen Revenue in Cancer Hormone Therapy Drugs Business (2015-2020) (Million US$)
Table 131. Aspen Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Cancer Hormone Therapy Drugs Market Share by Type: 2020 VS 2026
Figure 2. Tamoxifen Features
Figure 3. Aromatase Inhibitors Features
Figure 4. Antiandrogens Features
Figure 5. Androgen Synthesis Inhibitors Features
Figure 6. Other Features
Figure 7. Global Cancer Hormone Therapy Drugs Market Share by Application: 2020 VS 2026
Figure 8. Breast Cancer Case Studies
Figure 9. Prostate Cancer Case Studies
Figure 10. Cancer Hormone Therapy Drugs Report Years Considered
Figure 11. Global Cancer Hormone Therapy Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cancer Hormone Therapy Drugs Market Share by Regions: 2020 VS 2026
Figure 13. Global Cancer Hormone Therapy Drugs Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cancer Hormone Therapy Drugs Market Share by Players in 2019
Figure 16. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Hormone Therapy Drugs as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cancer Hormone Therapy Drugs Revenue in 2019
Figure 18. North America Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cancer Hormone Therapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020)
Figure 27. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Amgen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020)
Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020)
Figure 31. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Teva Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020)
Figure 33. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Takeda Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020)
Figure 35. Samyang Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Samyang Biopharmaceuticals Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020)
Figure 37. Tolmar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Tolmar Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020)
Figure 39. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. AstraZeneca Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020)
Figure 41. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Novartis Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020)
Figure 43. Aspen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Aspen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed